Improved Pharmaceutical Compositions Of Pimobendan

Patent No. EP2925305 (titled "Improved Pharmaceutical Compositions Of Pimobendan") was filed by Boehringer Ingelheim on Dec 1, 2014. The application was issued on Jul 27, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CEVA SANTE ANIMALEApr 27, 2017CABINET BECKER ET ASSOCIES

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2925305

BOEHRINGER INGELHEIM
Application Number
EP14824382A
Filing Date
Dec 1, 2014
Status
Opposition Rejected
Nov 15, 2019
Publication Date
Jul 27, 2016